The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic
NCT ID: NCT04847362
Last Updated: 2021-11-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
74 participants
INTERVENTIONAL
2021-04-11
2022-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
The mothers in this group will be given telehealth training for 4 weeks.
Experimental
education group
Control
Mothers in this group will not be given telehealth education, they will receive care within the scope of routine care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental
education group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Giving birth at term (between 38-42 weeks of gestation)
* Being on the 7th Postpartum Day,
* Participation in the study is voluntary,
* Absence of any psychiatric illness,
* Women who have characteristics such as not using any psychiatric medication.
* Baby with normal birth weight and APGAR score of 8 and above
* Those who have not developed postpartum complications
* Speaks and understands Turkish
Exclusion Criteria
\-
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YASEMİN AYDIN KARTAL
ASSOCIATE PROFESSOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zeynep Kamil Women's and Children's Diseases Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Saglık Bilimleri Universitesi
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
LEYLA KAYA
Role: primary
YASEMİN AYDIN KARTAL
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11.04.2021-27076
Identifier Type: -
Identifier Source: org_study_id